If your client does not feel the effects after 2 3 injections, then it is more than likely that they are not B12 deficient
(1998) characterized ipamorelin as the first selective GH secretagogue, demonstrating GH release without significant effects on ACTH, cortisol, or prolactin at GH-maximizing doses [2]
In this context, fibroblast growth factor 21 (FGF21) analogues are attractive because they target multiple components of MASH biology simultaneously, with potential to improve steatosis, inflammation, fibrosis, and broader cardiometabolic risk
[6] Nagele P, Zeugswetter B, Wiener C, et al
IGF-1 production, on the other hand, is part of the Growth Hormone (Somatotropic) Axis : The hypothalamus releases Growth Hormone-Releasing Hormone (GHRH)